Su1396 Crohn's Disease Outpatients Treated With Adalimumab Have an Earlier Loss of Response and Requirement for Dose Intensification Compared to Infliximab

✍ Scribed by Ma, Christopher; Huang, Vivian; Fedorak, Darryl K.; Kroeker, Karen I.; Dieleman, Levinus A.; Fedorak, Richard N.

• Book ID: 122161563
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 532 KB
• Volume: 146
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(14)61639-5